##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 79 Download : 68

##plugins.themes.academic_pro.article.main##

Abstract

Dendrimers are a brand-new type of polymer. They're monodisperse macromolecules with a lot of branches. Dendrimers' structural advantages enable them to play a significant role in nanotechnology, pharmaceuticals, and medicinal chemistry. Dendrimers are ideal for a wide range of biological and industrial applications due to their unique behavior. The bioactive substances can be easily encapsulated into the inside of the dendrimers or chemically conjugated or physically adsorbed onto the dendrimer surface, tailoring the carrier's desirable features to the active material's unique demands and therapeutic applications. The goal of the study is to highlight the production, characterization, drug delivery, and potential applications of dendrimers in diverse research, technological, and therapy fields.

Keywords

Drug delivery Types synthesis characteristics

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Kavinila.S, Lavanya.B, Vigneshwaran.L, & Senthil Kumar.M. (2022). Dendrimers: A Novel Trend of Nanocarriers. Texas Journal of Medical Science, 7, 47–59. https://doi.org/10.62480/tjms.2022.vol7.pp47-59
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Huang YW, Cambre M, Lee HJ. The toxicity of nanoparticles depends on multiple molecular and physicochemical mechanisms. International journal of molecular sciences. 2017 Dec;18(12):2702.
  2. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Particle and fiber toxicology. 2005 Dec;2(1):1-35.
  3. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. A new class of polymers: starburst-dendritic macromolecules. Polymer journal. 1985 Jan;17(1):117-32.
  4. Newkome GR, Yao Z, Baker GR, Gupta VK. Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol. The Journal of Organic Chemistry. 1985 May;50(11):2003-4.
  5. Lyu Z, Ding L, Huang AT, Kao CL, Peng L. Poly (amidoamine) dendrimers: Covalent and supramolecular synthesis. Materials Today Chemistry. 2019 Sep 1;13:34-48.
  6. Noriega-Luna B, Godínez LA, Rodríguez FJ, Rodríguez A, Zaldívar-Lelo de Larrea G, Sosa-Ferreyra CF, Mercado-Curiel RF, Manríquez J, Bustos E. Applications of dendrimers in drug delivery agents, diagnosis, therapy, and detection. Journal of Nanomaterials. 2014 Jan 1;2014.
  7. Bauer RE, Enkelmann V, Wiesler UM, Berresheim AJ, Müllen K. Single‐Crystal Structures of Polyphenylene Dendrimers. Chemistry–A European Journal. 2002 Sep 2;8(17):3858-64.
  8. Ihre H, Hult A, Fréchet JM, Gitsov I. Double-stage convergent approach for the synthesis of functionalized dendritic aliphatic polyesters based on 2, 2-bis (hydroxymethyl) propionic acid. Macromolecules. 1998 Jun 30;31(13):4061-8.
  9. Mane PP, Jadhav VS, Humbe VP, Hakke SC, Kale BB. Dendrimer: A novel polymer and tool for drug delivery. Am. J. Pharm Res. 2014;4:3851-62.
  10. Bosman DA, Janssen HM, Meijer EW. About dendrimers: structure, physical properties, and applications. Chemical reviews. 1999 Jul 14;99(7):1665-88.
  11. Purohit G, Sakthivel T, Florence AT. The interaction of cationic dendrons with albumin and their diffusion through cellulose membranes. International journal of pharmaceutics. 2003 Mar 18;254(1):37-41.
  12. Florence AT, Sakthivel T, Toth I. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. Journal of Controlled Release. 2000 Mar 1;65(1-2):253-9.
  13. Kim Y, Klutz AM, Jacobson KA. Systematic investigation of polyamidoamine dendrimers surface-modified with poly (ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. Bioconjugate chemistry. 2008 Aug 20;19(8):1660-72.
  14. Padilla De Jesús OL, Ihre HR, Gagne L, Fréchet JM, Szoka FC. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjugate chemistry. 2002 May 15;13(3):453-61.
  15. Sampathkumar SG, Yarema KJ. Dendrimers in cancer treatment and diagnosis. Nanotechnologies for the Life Sciences: Online. 2007 Sep 15.
  16. Gillies ER, Frechet JM. Dendrimers and dendritic polymers in drug delivery. Drug discovery today. 2005 Jan 1;10(1):35-43.
  17. Parajapati SK, Maurya SD, Das MK, Tilak VK, Verma KK, Dhakar RC. Potential application of dendrimers in drug delivery: A concise review and update. Journal of Drug Delivery and Therapeutics. 2016 Mar 14;6(2):71-88.
  18. Vandamme TF, Brobeck L. Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. Journal of controlled release. 2005 Jan 20;102(1):23-38.
  19. Trivedi V, Patel U, Bhimani B, Daslaniya D, Patel G, Vyas B. Dendrimer: polymer of 21st century. IJPRBS Journal. 2012;1(2):1-21.
  20. Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, Diwan PV. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. Journal of controlled release. 2003 Jul 31;90(3):335-43.
  21. Klajnert B, Bryszewska M. Dendrimers: properties and applications. Acta biochimica polonica. 2001 Mar 31;48(1):199-208.
  22. Cheng Y, Xu T. The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs. European journal of medicinal chemistry. 2008 Nov 1;43(11):2291-7.
  23. Bai S, Thomas C, Ahsan F. Dendrimers as a carrier for pulmonary delivery of enoxaparin, low-molecular-weight heparin. Journal of pharmaceutical sciences. 2007 Aug 1;96(8):2090-106.
  24. Mehta P, Kadam S, Pawar A, Bothiraja C. Dendrimers for pulmonary delivery: current perspectives and future challenges. New Journal of Chemistry. 2019;43(22):8396-409.
  25. Talanov VS, Regino CA, Kobayashi H, Bernardo M, Choyke PL, Brechbiel MW. Dendrimer-based nanoprobe for dual-modality magnetic resonance and fluorescence imaging. Nano Letters. 2006 Jul 12;6(7):1459-63.
  26. Sideratou Z, Tsiourvas D, Paleos CM. Quaternized poly (propylene imine) dendrimers as novel pH-sensitive controlled-release systems. Langmuir. 2000 Feb 22;16(4):1766-9.
  27. Pannier AK, Shea LD. Controlled release systems for DNA delivery. Molecular Therapy. 2004 Jul 1;10(1):19-26.
  28. Pushkar S, Philip A, Pathak K, Pathak D. Dendrimers: Nanotechnology derived novel polymers in drug delivery. Indian Journal of Pharmaceutical Education and Research. 2006;40(3):153.
  29. Klajnert B, Bryszewska M. Dendrimers: properties and applications. Acta biochimica polonica. 2001 Mar 31;48(1):199-208.
  30. Zimmerman SC, Lawless LJ. Supramolecular chemistry of dendrimers. InDendrimers Iv 2001 (pp. 95-120). Springer, Berlin, Heidelberg.
  31. Wang H, Chang H, Zhang Q, Cheng Y. Fabrication of low-generation dendrimers into nanostructures for efficient and non-toxic gene delivery. Polymeric Gene Delivery Systems. 2017:217-32.
  32. Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
  33. Frechet JM. Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. Science. 1994 Mar 25;263(5154):1710-5.
  34. Sakthivel T, Toth I, Florence AT. Synthesis and physicochemical properties of lipophilic polyamide dendrimers. Pharmaceutical research. 1998 May;15(5):776-82.
  35. Mittal P, Saharan A, Verma R, Altalbawy F, Alfaidi MA, Batiha GE, Akter W, Gautam RK, Uddin M, Rahman M. Dendrimers: a new race of pharmaceutical nanocarriers. BioMed Research International. 2021 Feb 15;2021.
  36. Hawker CJ, Frechet JM. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. Journal of the American Chemical Society. 1990 Oct;112(21):7638-47.
  37. Tripathy S, Baro L, Das MK. Dendrimer chemistry and host-guest interactions for drug targeting. International Journal of Pharmaceutical Sciences and Research. 2014 Jan 1;5(1):16.
  38. Gillies ER, Fréchet JM. Designing macromolecules for therapeutic applications: polyester dendrimer poly (ethylene oxide)“bow-tie” hybrids with tunable molecular weight and architecture. Journal of the American Chemical Society. 2002 Nov 27;124(47):14137-46.
  39. Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, Hanifehpour Y, Nejati-Koshki K, Pashaei-Asl R. Dendrimers: synthesis, applications, and properties. Nanoscale research letters. 2014 Dec;9(1):1-0.
  40. Grayson SM, Frechet JM. Convergent dendrons and dendrimers: from synthesis to applications. Chemical reviews. 2001 Dec 12;101(12):3819-68.
  41. Hawker CJ, Frechet JM. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. Journal of the American Chemical Society. 1990 Oct;112(21):7638-47.
  42. Caminade AM, Turrin CO, Laurent R, Ouali A, Delavaux-Nicot B, editors. Dendrimers: towards catalytic, material, and biomedical uses. John Wiley & Sons; 2011 Aug 31.
  43. Parata A, Felder-Flescha D. General introduction on dendrimers, classical versus accelerated syntheses and characterizations. Dendrimers in Nanomedicine; Jenny Stanford Publishing: New York, NY, USA. 2016:1-22.
  44. Grayson SM, Frechet JM. Convergent dendrons and dendrimers: from synthesis to applications. Chemical reviews. 2001 Dec 12;101(12):3819-68.
  45. Alper J. Rising Chemical" Stars" Could Play Many Roles: Enormous polymers that grow from a tiny core might be used in drug delivery, filtering, catalysis—even artificial cells. Science. 1991 Mar 29;251(5001):1562-4.
  46. Klajnert B, Bryszewska M. Dendrimers: properties and applications. Acta biochimica polonica. 2001 Mar 31;48(1):199-208.
  47. Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Advanced drug delivery reviews. 2012 Dec 1;64:102-15.
  48. Jain NK, editor. Advances in controlled and novel drug delivery. CBS Publishers & Distributors; 2008.
  49. Fischer M, Vögtle F. Dendrimers: from design to application—a progress report. Angewandte Chemie International Edition. 1999 Apr 1;38(7):884-905.
  50. Wiener EC, Auteri FP, Chen JW, Brechbiel MW, Gansow OA, Schneider DS, Belford RL, Clarkson RB, Lauterbur PC. Molecular Dynamics of Ion− Chelate Complexes Attached to Dendrimers. Journal of the American Chemical Society. 1996 Aug 21;118(33):7774-82.
  51. Bryant Jr LH, Brechbiel MW, Wu C, Bulte JW, Herynek V, Frank JA. Synthesis and relaxometry of high‐generation (G= 5, 7, 9, and 10) PAMAM dendrimer‐DOTA‐gadolinium chelates. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine. 1999 Feb;9(2):348-52.
  52. Nieznański K, Nieznańska H, Surewicz WK, Surewicz K, Bandyszewska M, inventors; Instytut Biologii Doswiadczalnej Im Marcelego Nenckiego Polskiej Akadamii Nauk, Case Western Reserve University, assignee. Prion protein-dendrimer conjugates for use in treatment of alzheimer disease. United States patent US 10,815,292. 2020 Oct 27.
  53. Wu HC, Chen-Yun YE, inventors; Academia Sinica, assignee. Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer. United States patent application US 16/062,274. 2021 Aug 5.
  54. Santos A, Veiga F, Figueiras A. Dendrimers as pharmaceutical excipients: Synthesis, properties, toxicity, and biomedical applications. Materials. 2019 Dec 21;13(1):65.